Gov. JB Pritzker named Doug Peterson, the director of AI strategy and implementation for Chicago-based pharmaceutical company ...

Following the release of upbeat data and given some recent signs of stabilization in the stocks, MarketWatch took at look at companies in the healthcare sector that are expected to produce the fastest ...

The Mayo Super League title race is heating up after a dramatic round of midweek fixtures saw twists at the top of the table.

Novo Nordisk announces that CVS Caremark®, the country's largest PBM, has decided Wegovy® will be the preferred GLP-1 ...

Xiangxiang Ma, a partner of Anjie Broad Law Firm, explores the various ways in which a recent U.S. executive order on drug pricing is impacting Chinese pharmaceutical companies’ license-out model ...

The Dividend Aristocrats are a group of 69 stocks in the S&P 500 Index with over 25 consecutive years of dividend increases. These high-quality businesses have managed recessions and various crises, ...

AbbVie inched up 0.17% to $187.66, bucking the broader market’s downward trend. While the S&P 500 dipped 0.53%, AbbVie ...

ROCKVILLE, MD, USA I June 5, 2025 I REGENXBIO Inc. (Nasdaq: RGNX) today announced new positive interim data from the Phase ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

There are many solid dividend stocks right now worth considering because they trade at modest valuations. Three stocks, in ...

Investors are swarming AbbVie with bullish bets, as call options surged past expectations and sent volatility ticking up.